Stockreport

Ultromics obtains Breakthrough Device FDA clearance for its Cardiac Amyloidosis screening device through the Total Product Lifecycle Advisory Program [Yahoo! Finance]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF EchoGo ® Amyloidosis sits on Ultromics' EchoGo ® platform complementing the existing commercialized EchoGo ® Heart Failure device. OXFORD, England Nov. 20, 2024 /PRNe [Read more]